BDD is a speciality formulation company located in BioCity, Glasgow. The team have recently raised an investment round to progress their Oralogik ™ timed drug release technology a patented pH Insensitive technology.
BDD offer a full service package to fit individual needs from troubleshooting, formulation development, in vitro and in vivo testing and full technology transfer. OralogiK provides unrivalled control of drug release at the right place and time.
Their clinical division provides a full clinical package, including protocol development, study documentation design and regulatory authority submission, through to close out and production of ICH GCP-compliant clinical study report.
BDD specialise in gamma scintigraphy, a powerful and versatile technology used to investigate the in vivo behaviour of your formulation. Coupled with pharmacokinetic data, this technique can be used to provide information on time /site of disintegration, gastric emptying, GI transit and intra/ inter individual differences.